Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 10.47B | £ 11.25B | £ 10.02B | £ 9.48B | £ 8.25B |
Total Assets | £ 10.99B | £ 11.68B | £ 10.48B | £ 9.90B | £ 8.74B |
Total Debt | £ 109.20M | £ 109.40M | £ 111.00M | £ 110.40M | £ 109.70M |
Net Debt | £ -10.36B | £ -11.14B | £ -9.91B | £ -9.37B | £ -8.14B |
Total Liabilities | £ 10.66B | £ 11.34B | £ 10.19B | £ 9.65B | £ 8.52B |
Stockholders Equity | £ 338.50M | £ 341.50M | £ 286.70M | £ 253.20M | £ 217.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |